Clinical impact of Ocrelizumab dosing delays and their association with CD-19+ B-cell repletion during the COVID-19 pandemic


By Dr Nitin Sahi, Neurology SpR, University Hospitals of North Midlands NHS Trust

Runner-up

This project was awarded runner-up .

View more projects
Poster

Write up

More MS Academy Medication Projects

Initiating a new Disease Modifying Treatment (DMT) into an existing service
By Sarah Hughes, Multiple Sclerosis Specialist Nurse, Torbay and South Devon NHS Foundation Trust
Reducing Delays to DMT Initiation via Homecare Prescriptions in Multiple Sclerosis
By Rebecca Harrison, Specialist Pharmacist for Neurology & Stroke Band 8, Royal United Hospitals Bath NHS Foundation Trust
Encouraging excellence, developing leaders, inspiring change

MS Academy was established five years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.